In Vitro Evaluation of Amide-Linked Coumarin Scaffolds for the Inhibition of α-Synuclein and Tau Aggregation
ACS Omega 2025, XXXX, XXX, XXX-XXX, DOI: 10.1021/acsomega.5c02435
Physical and Mechanical Properties of Monomeric Alpha-Synuclein Provide Leads to Molecular Function
J. Phys. Chem. B 2025, XXXX, XXX, XXX-XXX DOI: 10.1021/acs.jpcb.5c03200
Perilla-derived chalcone inhibits α-synuclein fibrillization and prevents aggregate-induced disruption of intracellular α-synuclein conformation in neuronal cells
Science Direct (2025) (779), DOI: 10.1016/j.bbrc.2025.152452.
Synaptic enrichment of pSer129 alpha-synuclein correlates with dopaminergic denervation in early-stage Parkinson’s disease
Nat Commun 16, 6630 (2025). DOI: 10.1038/s41467-025-61052-1
α-Synuclein fibrils enhance HIV-1 infection of human T cells, macrophages and microglia
Nat Commun 16, 813 (2025). DOI: 10.1038/s41467-025-56099-z
Early increase of the synaptic blood marker β-synuclein in asymptomatic autosomal dominant Alzheimer's disease
Alzheimers Dement (2025) 21 (4), e70146 DOI: 10.1002/alz.70146
TDP-43 seeding activity in the olfactory mucosa of patients with amyotrophic lateral sclerosis
Mol Neurodegener (2025) 20 (1), 49 DOI: 10.1186/s13024-025-00833-0
Recursive seed amplification detects distinct α-synuclein strains in cerebrospinal fluid of patients with Parkinson's disease
Acta Neuropathol Commun (2025) 13 (1), 13 DOI: 10.1186/s40478-024-01923-8
Autoantibodies against α-synuclein inhibit its aggregation and cytotoxicity
J Autoimmun (2025) 152, 103390 DOI: 10.1016/j.jaut.2025.103390
A nanoparticle-based wireless deep brain stimulation system that reverses Parkinson’s disease
Sci Adv (2025) 11 (3), eado4927 DOI: 10.1126/sciadv.ado4927